nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.214	0.329	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.214	0.329	CbGbCtD
Fluticasone Propionate—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.16	0.247	CbGbCtD
Fluticasone Propionate—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0625	0.0961	CbGbCtD
Fluticasone Propionate—Pustular psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0486	0.206	CcSEcCtD
Fluticasone Propionate—Plaque psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0486	0.206	CcSEcCtD
Fluticasone Propionate—NR3C2—nephron—focal segmental glomerulosclerosis	0.0212	0.265	CbGeAlD
Fluticasone Propionate—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.0097	0.0411	CcSEcCtD
Fluticasone Propionate—Hypertrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.0077	0.0326	CcSEcCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00597	0.0747	CbGeAlD
Fluticasone Propionate—SERPINA6—nephron tubule—focal segmental glomerulosclerosis	0.0056	0.07	CbGeAlD
Fluticasone Propionate—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00511	0.0639	CbGeAlD
Fluticasone Propionate—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.0213	CcSEcCtD
Fluticasone Propionate—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.0213	CcSEcCtD
Fluticasone Propionate—SERPINA6—kidney—focal segmental glomerulosclerosis	0.00492	0.0615	CbGeAlD
Fluticasone Propionate—PLA2G4A—cortex of kidney—focal segmental glomerulosclerosis	0.00481	0.0602	CbGeAlD
Fluticasone Propionate—SERPINA6—cortex of kidney—focal segmental glomerulosclerosis	0.00479	0.0599	CbGeAlD
Fluticasone Propionate—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0197	CcSEcCtD
Fluticasone Propionate—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0197	CcSEcCtD
Fluticasone Propionate—NR3C2—nephron tubule—focal segmental glomerulosclerosis	0.00457	0.0572	CbGeAlD
Fluticasone Propionate—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.0174	CcSEcCtD
Fluticasone Propionate—NR3C2—kidney—focal segmental glomerulosclerosis	0.00402	0.0502	CbGeAlD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.00392	0.117	CbGpPWpGaD
Fluticasone Propionate—NR3C2—cortex of kidney—focal segmental glomerulosclerosis	0.00391	0.0489	CbGeAlD
Fluticasone Propionate—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0153	CcSEcCtD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.00335	0.1	CbGpPWpGaD
Fluticasone Propionate—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.0137	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0135	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0135	CcSEcCtD
Fluticasone Propionate—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.013	CcSEcCtD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.00301	0.0901	CbGpPWpGaD
Fluticasone Propionate—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.012	CcSEcCtD
Fluticasone Propionate—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.0118	CcSEcCtD
Fluticasone Propionate—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00247	0.0309	CbGeAlD
Fluticasone Propionate—NR3C1—nephron tubule—focal segmental glomerulosclerosis	0.00245	0.0307	CbGeAlD
Fluticasone Propionate—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.0103	CcSEcCtD
Fluticasone Propionate—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.01	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00942	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0093	CcSEcCtD
Fluticasone Propionate—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00217	0.0272	CbGeAlD
Fluticasone Propionate—NR3C1—kidney—focal segmental glomerulosclerosis	0.00215	0.0269	CbGeAlD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00212	0.0634	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00211	0.0264	CbGeAlD
Fluticasone Propionate—NR3C1—cortex of kidney—focal segmental glomerulosclerosis	0.0021	0.0262	CbGeAlD
Fluticasone Propionate—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.0081	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00783	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00765	CcSEcCtD
Fluticasone Propionate—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00748	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00746	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00723	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00702	CcSEcCtD
Fluticasone Propionate—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00698	CcSEcCtD
Fluticasone Propionate—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00694	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00694	CcSEcCtD
Fluticasone Propionate—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00163	0.0204	CbGeAlD
Fluticasone Propionate—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00674	CcSEcCtD
Fluticasone Propionate—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00654	CcSEcCtD
Fluticasone Propionate—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00651	CcSEcCtD
Fluticasone Propionate—NR3C1—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00148	0.0443	CbGpPWpGaD
Fluticasone Propionate—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00619	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00618	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00612	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00561	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00556	CcSEcCtD
Fluticasone Propionate—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00545	CcSEcCtD
Fluticasone Propionate—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00542	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00521	CcSEcCtD
Fluticasone Propionate—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00511	CcSEcCtD
Fluticasone Propionate—PLA2G4A—ADP signalling through P2Y purinoceptor 1—GNAQ—focal segmental glomerulosclerosis	0.0012	0.036	CbGpPWpGaD
Fluticasone Propionate—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00508	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00503	CcSEcCtD
Fluticasone Propionate—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00498	CcSEcCtD
Fluticasone Propionate—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00495	CcSEcCtD
Fluticasone Propionate—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00489	CcSEcCtD
Fluticasone Propionate—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00473	CcSEcCtD
Fluticasone Propionate—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00468	CcSEcCtD
Fluticasone Propionate—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00461	CcSEcCtD
Fluticasone Propionate—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00461	CcSEcCtD
Fluticasone Propionate—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0046	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00458	CcSEcCtD
Fluticasone Propionate—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00456	CcSEcCtD
Fluticasone Propionate—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00451	CcSEcCtD
Fluticasone Propionate—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00442	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00442	CcSEcCtD
Fluticasone Propionate—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00439	CcSEcCtD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00103	0.0308	CbGpPWpGaD
Fluticasone Propionate—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00434	CcSEcCtD
Fluticasone Propionate—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0043	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signal amplification—GNAQ—focal segmental glomerulosclerosis	0.00101	0.0303	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000952	0.00403	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.00394	CcSEcCtD
Fluticasone Propionate—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000893	0.00378	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—ACTA2—focal segmental glomerulosclerosis	0.000861	0.0257	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000861	0.00365	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000854	0.00362	CcSEcCtD
Fluticasone Propionate—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00083	0.00351	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—ACTN4—focal segmental glomerulosclerosis	0.000829	0.0248	CbGpPWpGaD
Fluticasone Propionate—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000826	0.0035	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000826	0.0035	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.000807	0.0241	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.00326	CcSEcCtD
Fluticasone Propionate—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000739	0.00313	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000715	0.00303	CcSEcCtD
Fluticasone Propionate—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000691	0.00293	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Endothelins—TRPC6—focal segmental glomerulosclerosis	0.000688	0.0206	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000664	0.00281	CcSEcCtD
Fluticasone Propionate—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00279	CcSEcCtD
Fluticasone Propionate—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000658	0.00279	CcSEcCtD
Fluticasone Propionate—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000654	0.00277	CcSEcCtD
Fluticasone Propionate—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00062	0.00263	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.00058	0.0173	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.000575	0.0172	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.000541	0.0162	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000525	0.0157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000496	0.0148	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—PCNA—focal segmental glomerulosclerosis	0.000486	0.0145	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—EDN1—focal segmental glomerulosclerosis	0.000446	0.0133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000327	0.00979	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.000326	0.00974	CbGpPWpGaD
Fluticasone Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—focal segmental glomerulosclerosis	0.000308	0.00922	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—EDN1—focal segmental glomerulosclerosis	0.00029	0.00867	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.000285	0.00852	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000279	0.00835	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000271	0.0081	CbGpPWpGaD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.000268	0.00801	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000257	0.00767	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.000252	0.00754	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—AGT—focal segmental glomerulosclerosis	0.000241	0.0072	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	0.000224	0.00671	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.000211	0.0063	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.00021	0.00628	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000181	0.00542	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.000171	0.00513	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000166	0.00495	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—focal segmental glomerulosclerosis	0.000165	0.00492	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000156	0.00467	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000147	0.00439	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MMP9—focal segmental glomerulosclerosis	0.000142	0.00424	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.00013	0.00389	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000125	0.00375	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000124	0.00369	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000122	0.00364	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—TGFB1—focal segmental glomerulosclerosis	0.00012	0.00358	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000117	0.0035	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TGFB1—focal segmental glomerulosclerosis	0.000117	0.00349	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000113	0.00337	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000109	0.00325	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000107	0.00321	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000104	0.00312	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000104	0.00311	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	9.44e-05	0.00282	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	9.03e-05	0.0027	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.68e-05	0.00259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	7.71e-05	0.00231	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—CTGF—focal segmental glomerulosclerosis	7.52e-05	0.00225	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	7.46e-05	0.00223	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.44e-05	0.00222	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	7.41e-05	0.00222	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	7.4e-05	0.00221	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.33e-05	0.00219	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	7.12e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	7.12e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	7.09e-05	0.00212	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.58e-05	0.00197	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—FN1—focal segmental glomerulosclerosis	6.46e-05	0.00193	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NOS2—focal segmental glomerulosclerosis	6.38e-05	0.00191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.36e-05	0.0019	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.23e-05	0.00186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.99e-05	0.00179	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.7e-05	0.0017	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	5.63e-05	0.00168	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—LIPC—focal segmental glomerulosclerosis	5.43e-05	0.00162	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.39e-05	0.00161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	5.37e-05	0.00161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—ALB—focal segmental glomerulosclerosis	5.36e-05	0.0016	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.36e-05	0.0016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.88e-05	0.00146	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.83e-05	0.00145	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CTGF—focal segmental glomerulosclerosis	4.78e-05	0.00143	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.51e-05	0.00135	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.4e-05	0.00132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.4e-05	0.00132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.38e-05	0.00131	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CTGF—focal segmental glomerulosclerosis	4.35e-05	0.0013	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.12e-05	0.00123	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	4.12e-05	0.00123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.01e-05	0.0012	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	3.78e-05	0.00113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.68e-05	0.0011	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.49e-05	0.00105	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	3.43e-05	0.00103	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.39e-05	0.00101	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.39e-05	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.37e-05	0.00101	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	3.33e-05	0.000996	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—LPL—focal segmental glomerulosclerosis	3.31e-05	0.000991	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.21e-05	0.00096	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.07e-05	0.000918	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.9e-05	0.000867	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.85e-05	0.000854	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AGT—focal segmental glomerulosclerosis	2.83e-05	0.000847	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.77e-05	0.000828	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	2.73e-05	0.000818	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.68e-05	0.000802	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.62e-05	0.000785	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.41e-05	0.00072	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.37e-05	0.000709	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.31e-05	0.00069	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.23e-05	0.000667	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.22e-05	0.000663	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.19e-05	0.000655	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—focal segmental glomerulosclerosis	2.17e-05	0.00065	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	1.98e-05	0.000593	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	1.97e-05	0.000591	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.82e-05	0.000545	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.71e-05	0.000511	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	1.67e-05	0.000499	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.52e-05	0.000453	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.43e-05	0.000427	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.41e-05	0.000421	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.4e-05	0.000417	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.27e-05	0.00038	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.15e-05	0.000344	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.12e-05	0.000335	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.1e-05	0.000328	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.03e-05	0.000308	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	7.76e-06	0.000232	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	6.64e-06	0.000198	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	5.09e-06	0.000152	CbGpPWpGaD
